M

Researcher Profile

Magdalena Sanchez-Hohl

2

Publications

485

Citations

10

Co-Authors

2

Active Years

Publications

Open Access Journal Article Annals of Oncology Feb 01, 2022

A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial

R.A. Soo · J.-Y. Han · U. Dafni · B.C. Cho +87 more

10.1016/j.annonc.2021.11.010 85 citations

Journal Article The Lancet Oncology Mar 01, 2019

Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial

Sherene Loi · Anita Giobbie-Hurder · Andrea Gombos · Thomas Bachelot +54 more

10.1016/s1470-2045(18)30812-x 400 citations

Publication Timeline

2022

1

2019

1

Frequent Co-Authors

Sabrina Ribeli-Hofmann

Anita Hiltbrunner

Michela Frapolli

Thomas Bachelot

Mariano Provencio Pulla

Charitini Andriakopoulou